Qube Research & Technologies increases its short position on Grifols to 1.23%, up from 1.19%, amid market volatility due to the conflict with Gotham City Research....
More than 60% of the €1.27 billion allocated to R&D in 2021 was devoted to clinical trials (€789 million), where Spain plays a prominent international role,...